Rebound Hyperglycemia
Rebound Hyperglycemia is a physiological phenomenon in the context of hypoglycemic drug toxicity characterized by an acute elevation in blood glucose levels following an episode of hypoglycemia, resulting from counterregulatory hormone responses that overshoot normal glycemic regulation.
54
Publications
3K
Citations
259
Authors
99
Institutions
Publications per year
2017–2026
8
Variants
Somogyi EffectSomogyi Phenomenon
Parents
54
A transplantable insulinoma in the rat.
William L. Chick, S. Warren, Rosanna N. Chute et al. · Proceedings of the National Academy of Sciences · 1977 · 308 citations · Full text
Medicine, Endocrinology, Surgery +17
Alan J. Garber, Yehuda Handelsman, Daniel Einhorn et al. · Endocrine Practice · 2008 · 239 citations
1–5 of 54
259
2
h-index
2
h-index
2
h-index
2
h-index
2
h-index
1–5 of 259
99
Stanford University
Stanford, United States
3 h-index
7 publications
841 citations
Harvard University
Cambridge, United States
3 h-index
9 publications
676 citations
Deaconess Hospital
Oklahoma City, United States
2 h-index
7 publications
1.2K citations
University of Siena
Siena, Italy
2 h-index
2 publications
59 citations
Mayo Clinic in Arizona
Scottsdale, United States
2 h-index
7 publications
197 citations

Joslin Diabetes Center
Boston, United States
2 h-index
10 publications
434 citations
University of California, Davis
Davis, United States
2 h-index
3 publications
315 citations

The University of Queensland
Brisbane, Australia
2 h-index
5 publications
123 citations
1–8 of 99
4 publications · 321 citations
4
h-index
2 publications · 278 citations
2
h-index
JCA · 2 publications · 73 citations
2
h-index
Repository · 2 publications · 41 citations
2
h-index
2 publications · 85 citations
2
h-index
1–5